Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Just One Stock: The Biopharma Veteran Facing a Landmark Stem Cell Trial
Seeking Alpha
Saturday, January 29, 2011 - 11:43am
tags:
Geron, stem cells
Value Investing, Biotech Style
Motley Fool
Saturday, January 29, 2011 - 11:35am
tags:
investors, Benlysta, Human Genome Sciences, GSK, Cell Therapeutics, obesity. Orexigen Therapeutics, Vertex Pharmaceuticals, Exelixis
Arena's Obese To-Do List
Motley Fool
Saturday, January 29, 2011 - 11:32am
tags:
Arena Pharmaceuticals, Qnexa, Vivus
BioTime acquires biotech company assets for $250K
Yahoo/AP
Saturday, January 29, 2011 - 11:30am
tags:
BioTime, Cell Targeting, OncoCyte Corp
AVEO Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Saturday, January 29, 2011 - 11:29am
tags:
Aveo Pharmaceutical, investors
FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma
BusinessWire
Saturday, January 29, 2011 - 11:24am
tags:
Roche Group, Biogen Idec, follicular lymphoma, Rituxan
Rats Plague Arena's Diet Pill
Minyanville
Saturday, January 29, 2011 - 11:20am
tags:
Arena Pharmaceuticals, Orexigen, obesity, diet drugs, Qnexa, Vivus
Harwood Feffer LLP Announces It Has Amended Its Class Action Complaint Against Genzyme Corporation
Yahoo/Globe NewsWire
Saturday, January 29, 2011 - 11:17am
tags:
Genzyme, lawsuits
Downtrend Spotted in Shares of KV Pharmaceutical (KV.A)
Benzinga
Saturday, January 29, 2011 - 11:15am
tags:
KV Pharmaceutical, investors
Digging For Data: M&A For Pharma IT Rises
Pharmalot
Friday, January 28, 2011 - 12:15pm
tags:
M&A
How GlaxoSmithKline Lost $635M in Bad Bets on Sleeping Pills
BNET Pharma
Friday, January 28, 2011 - 12:14pm
tags:
GSK, insomnia, Actelion, almorexant, Lunesta, Sunovion
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Friday, January 28, 2011 - 12:13pm
tags:
Orexigen, Contrave, Arena Pharmaceuticals, Vivus, Avanir, Discovery Labs, Cel-Sci
Earnings Preview: Pfizer report to focus on deals
Yahoo/AP
Friday, January 28, 2011 - 12:10pm
tags:
earnings, Pfizer, Medicines Company, Bristol-Myers Squibb
Myriad Genetics Falls After Sanofi Setback for Cancer Treatment
Bloomberg
Friday, January 28, 2011 - 12:09pm
tags:
Myriad Genetics, Sanofi, BSI-201, breast cancer
The Feds Are Investigating How Many Fraud Cases?
Pharmalot
Friday, January 28, 2011 - 9:44am
tags:
fraud, whistleblowers, HHS
Roche’s Tarceva Extends Lives, Study Stopped Early
Bloomberg
Friday, January 28, 2011 - 9:41am
tags:
Astellas, Tarceva, lung cancer, Roche
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Yahoo
Friday, January 28, 2011 - 9:40am
tags:
Endo, Orion, R&D, cancer
CyDex Pharmaceuticals sells to Ligand Pharmaceuticals
Bizjournals.com
Friday, January 28, 2011 - 9:39am
tags:
CyDex Pharmaceuticals, Ligand, M&A
Sales Potential and Chances of FDA Approval for DepoMed's DM-1796
Seeking Alpha
Friday, January 28, 2011 - 9:37am
tags:
FDA, DM-1796, Depomed, gabapentin, Pfizer, Abbott Laboratories, XenoPort
Arena Fires 25% of Workforce After Diet Drug Delay
Bloomberg
Thursday, January 27, 2011 - 9:39pm
tags:
Arena Pharmaceuticals, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.